News Digest / Income Statements / Balance Labs Q1 2025: Significant Loss Reduction Amid Rising Expenses and Financial Challenges

Balance Labs Q1 2025: Significant Loss Reduction Amid Rising Expenses and Financial Challenges

StockInvest.us
01:00pm, Tuesday, May 20, 2025
Illustration by StockInvest.us

Balance Labs, Inc. (PINK: BLNC) has released its financial results for the first quarter of 2025, ending March 31. Here’s a concise overview of the company's financial health and operational status.

Key Points and Statistics:

  • Net Loss: For Q1 2025, the net loss amounted to $6,406, a substantial reduction compared to a loss of $116,943 during the same period in 2024.
  • Operating Expenses: Total operating expenses reached $78,839, up from $65,718 in Q1 2024. This was driven primarily by increased professional fees (56% hike to $25,035).
  • Cash Balance: Cash and cash equivalents decreased sharply to $3,040 from $13,199 at the end of Q4 2024.
  • Accumulated Deficit: The accumulated deficit stood at $5,889,727 as of March 31, 2025.
  • Related Party Transactions: Significant reliance on related party loans, totalling $1,743,558, which are currently in default.
  • Future Plans: The company aims to raise additional capital to sustain operations and initiate a marketing campaign.
  • Going Concern: There is substantial doubt about the company's ability to continue as a going concern due to financial difficulties.
  • Operating Cash Flow: The company had cash used in operations of $22,659 for Q1 2025, compared to $37,045 for Q1 2024.

Positive Aspects:

  • The company successfully reduced its net loss by 95% compared to the previous year, largely due to the cancellation of an accounts payable balance.
  • Other income increased due to a significant gain on the settlement of an accounts payable, amounting to $127,579.

Negative Aspects:

  • Operating expenses are on the rise, especially in professional fees, which could pressure margins moving forward.
  • Date of financial statements raise concerns about liquidity, given the $5,077,512 working capital deficiency.
  • The company relies heavily on related party financing, which could pose risks, particularly as many of these loans are in default.

The challenges faced by Balance Labs, Inc. indicate a critical need for strategic financial management and operational efficiency to navigate the upcoming quarters. The company's efforts to secure further capital and manage its liabilities will be pivotal for its future viability.

About The Author

StockInvest.us

StockInvest.us is a stock market research tool that provides daily stock signals and technical analysis for over 25 000 tickers on 38 exchanges. The company was founded in 2016 in Vilnius, Lithuania.

Trusted Broker
Start Your Journey With:
eToro
0% Commission Stock Trading
Follow Other Investors Strategy
Wide variety: Crypto, stocks, ETFs

Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk.